Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical studies with sodium channel blockers in traumatic brain injury

May 6, 1997

Transdermal N-0923 effective in Parkinson's disease

May 6, 1997

COX-2 inhibitor shows potential for preventing neuronal death

May 6, 1997

FDA clears generic version of SKB's Compazine

May 6, 1997

FDA grants SciClone orphan drug status for CPX

May 6, 1997

Neuromyalgic response to rhNGF described

May 6, 1997

Helix BioPharma enters research and development agreement

May 6, 1997

Cytel and Schwarz terminate research collaboration

May 6, 1997

Salix to commence clinical trials with Normix

May 6, 1997

Rhone-Poulenc Rorer licenses Granocyte for additional countries

May 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...